Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonghan Yu

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|April 13, 2026
Independent prognostic value of the gene-only BCT Score compared with the 21-gene recurrence score in ER+/HER2- early breast cancerSung Gwe Ahn, Jonghan Yu, Sang Uk Woo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|January 17, 2024
Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched CohortDong Seung Shin, Yoon Ju Bang, Joon Young Choi, et al.
Frontiers in Oncology|May 1, 2025
Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatmentsSung Gwe Ahn, Jonghan Yu, Seung Ho Baek, et al.
The Oncologist|June 6, 2023
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast CancerHan-Byoel Lee, Kyung-Hun Lee, Seok Hyun Song, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2025
Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete responseCho Eun Lee, Seok Jin Nam, Seok Won Kim, et al.
Breast (Edinburgh, Scotland)|November 4, 2023
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancerNalee Kim, Ji-Yeon Kim, Won Park, et al.
Journal of Breast Cancer|November 28, 2025
Correlation Between Margin Status and Ipsilateral Breast Tumor Recurrence in Patients With Breast Cancer Undergoing Breast-Conserving Surgery With Whole-Breast Radiation TherapyKi Jo Kim, Seung Ah Lee, Doyoun Woen, et al.
Journal of Breast Cancer|November 20, 2023
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast CancerNalee Kim, Haeyoung Kim, Ji Hye Hwang, et al.
Radiation Oncology Journal|October 2, 2024
Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapyHyunki Park, Haeyoung Kim, Won Park, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|April 13, 2026
Independent prognostic value of the gene-only BCT Score compared with the 21-gene recurrence score in ER+/HER2- early breast cancerSung Gwe Ahn, Jonghan Yu, Sang Uk Woo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 15, 2025
Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of viewWoong Ki Park, Seok Jin Nam, Seok Won Kim, et al.
Journal of Breast Cancer|January 17, 2024
Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched CohortDong Seung Shin, Yoon Ju Bang, Joon Young Choi, et al.
Frontiers in Oncology|May 1, 2025
Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatmentsSung Gwe Ahn, Jonghan Yu, Seung Ho Baek, et al.
The Oncologist|June 6, 2023
A Survey of Practice Patterns for Clinical Nodal Staging Prior to Neoadjuvant Chemotherapy in Breast CancerHan-Byoel Lee, Kyung-Hun Lee, Seok Hyun Song, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 25, 2025
Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete responseCho Eun Lee, Seok Jin Nam, Seok Won Kim, et al.
Breast (Edinburgh, Scotland)|November 4, 2023
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancerNalee Kim, Ji-Yeon Kim, Won Park, et al.
Journal of Breast Cancer|November 28, 2025
Correlation Between Margin Status and Ipsilateral Breast Tumor Recurrence in Patients With Breast Cancer Undergoing Breast-Conserving Surgery With Whole-Breast Radiation TherapyKi Jo Kim, Seung Ah Lee, Doyoun Woen, et al.
Journal of Breast Cancer|November 20, 2023
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast CancerNalee Kim, Haeyoung Kim, Ji Hye Hwang, et al.
Radiation Oncology Journal|October 2, 2024
Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapyHyunki Park, Haeyoung Kim, Won Park, et al.
Pageof 14